Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
Preliminary evidence of endotoxic activity of Bilophila wadsworthia.

Anaerobe

Mosca A, D'Alagni M, Del Prete R, De Michele GP, Summanen PH, Finegold SM, Miragliotta G.
PMID: 16887503
Anaerobe. 1995 Feb;1(1):21-4. doi: 10.1016/s1075-9964(95)80379-3.

In this study we describe two properties of the Gram-negative bacterium Bilophila wadsworthia, namely the ability to clot Limulus lysate and the capacity to induce the production of tissue factor-like procoagulant activity by human mononuclear cells in vitro. Although...

Cite
Mosca A, D'Alagni M, Del Prete R, et al. Preliminary evidence of endotoxic activity of Bilophila wadsworthia. Anaerobe. 1995;1(1):21-4doi: 10.1016/s1075-9964(95)80379-3.
Mosca, A., D'Alagni, M., Del Prete, R., De Michele, G. P., Summanen, P. H., Finegold, S. M., & Miragliotta, G. (1995). Preliminary evidence of endotoxic activity of Bilophila wadsworthia. Anaerobe, 1(1), 21-4. https://doi.org/10.1016/s1075-9964(95)80379-3
Mosca, A, et al. "Preliminary evidence of endotoxic activity of Bilophila wadsworthia." Anaerobe vol. 1,1 (1995): 21-4. doi: https://doi.org/10.1016/s1075-9964(95)80379-3
Mosca A, D'Alagni M, Del Prete R, De Michele GP, Summanen PH, Finegold SM, Miragliotta G. Preliminary evidence of endotoxic activity of Bilophila wadsworthia. Anaerobe. 1995 Feb;1(1):21-4. doi: 10.1016/s1075-9964(95)80379-3. PMID: 16887503.
Copy Download .nbib Format: NLM
Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells.

Anaerobe

Gerardo SH, Garcia MM, Wexler HM, Finegold SM.
PMID: 16887620
Anaerobe. 1998 Feb;4(1):19-27. doi: 10.1006/anae.1997.0134.

Adherence of Bilophila wadsworthia to the cultured human embryonic intestinal cell line, Intestine 407 (Int 407), varied among the strains tested from strongly adherent (76-100% cells positive for one or more adherent bacteria) to non- or weakly adherent (0-25%...

Cite
Gerardo SH, Garcia MM, Wexler HM, et al. Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells. Anaerobe. 1998;4(1):19-27doi: 10.1006/anae.1997.0134.
Gerardo, S. H., Garcia, M. M., Wexler, H. M., & Finegold, S. M. (1998). Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells. Anaerobe, 4(1), 19-27. https://doi.org/10.1006/anae.1997.0134
Gerardo, S H, et al. "Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells." Anaerobe vol. 4,1 (1998): 19-27. doi: https://doi.org/10.1006/anae.1997.0134
Gerardo SH, Garcia MM, Wexler HM, Finegold SM. Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells. Anaerobe. 1998 Feb;4(1):19-27. doi: 10.1006/anae.1997.0134. PMID: 16887620.
Copy Download .nbib Format: NLM
Comparison of recovery of anaerobic bacteria using the Anoxomat, anaerobic chamber, and GasPak jar systems.

Anaerobe

Summanen PH, McTeague M, Väisänen ML, Strong CA, Finegold SM.
PMID: 16887656
Anaerobe. 1999 Feb;5(1):5-9. doi: 10.1006/anae.1999.0184.

The Anoxomat system provides an automated evacuation-replacement technique to create an anaerobic or microaerophilic environment in a jar. We evaluated the Anoxomat system for the growth of obligate anaerobes and for the recovery of anaerobic organisms from clinical specimens,...

Cite
Summanen PH, McTeague M, Väisänen ML, et al. Comparison of recovery of anaerobic bacteria using the Anoxomat, anaerobic chamber, and GasPak jar systems. Anaerobe. 1999;5(1):5-9doi: 10.1006/anae.1999.0184.
Summanen, P. H., McTeague, M., Väisänen, M. L., Strong, C. A., & Finegold, S. M. (1999). Comparison of recovery of anaerobic bacteria using the Anoxomat, anaerobic chamber, and GasPak jar systems. Anaerobe, 5(1), 5-9. https://doi.org/10.1006/anae.1999.0184
Summanen, P H, et al. "Comparison of recovery of anaerobic bacteria using the Anoxomat, anaerobic chamber, and GasPak jar systems." Anaerobe vol. 5,1 (1999): 5-9. doi: https://doi.org/10.1006/anae.1999.0184
Summanen PH, McTeague M, Väisänen ML, Strong CA, Finegold SM. Comparison of recovery of anaerobic bacteria using the Anoxomat, anaerobic chamber, and GasPak jar systems. Anaerobe. 1999 Feb;5(1):5-9. doi: 10.1006/anae.1999.0184. PMID: 16887656.
Copy Download .nbib Format: NLM
Taxonomy--General comments and update on taxonomy of Clostridia and Anaerobic cocci.

Anaerobe

Finegold SM, Song Y, Liu C.
PMID: 16887670
Anaerobe. 2002 Oct;8(5):283-5. doi: 10.1006/anae.2002.0436.

Since such things as sites of normal carriage, type and severity of infections produced, and antimicrobial susceptibility patterns may vary according to the particular species involved, accurate taxonomy for differentiation of species is important. For example, reclassification of the...

Cite
Finegold SM, Song Y, Liu C. Taxonomy--General comments and update on taxonomy of Clostridia and Anaerobic cocci. Anaerobe. 2002;8(5):283-5doi: 10.1006/anae.2002.0436.
Finegold, S. M., Song, Y., & Liu, C. (2002). Taxonomy--General comments and update on taxonomy of Clostridia and Anaerobic cocci. Anaerobe, 8(5), 283-5. https://doi.org/10.1006/anae.2002.0436
Finegold, Sydney M, et al. "Taxonomy--General comments and update on taxonomy of Clostridia and Anaerobic cocci." Anaerobe vol. 8,5 (2002): 283-5. doi: https://doi.org/10.1006/anae.2002.0436
Finegold SM, Song Y, Liu C. Taxonomy--General comments and update on taxonomy of Clostridia and Anaerobic cocci. Anaerobe. 2002 Oct;8(5):283-5. doi: 10.1006/anae.2002.0436. PMID: 16887670.
Copy Download .nbib Format: NLM
Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis.

Anaerobe

Linscott AJ, Flamholtz RB, Shukla D, Song Y, Liu C, Finegold SM.
PMID: 16701538
Anaerobe. 2005 Feb-Apr;11(1):97-8. doi: 10.1016/j.anaerobe.2004.10.002. Epub 2004 Nov 30.

Clostridium hathewayi and Campylobacter hominis have not been previously reported in infection. We report a fatal case of septicemia, massive intravascular hemolysis, shock, and disseminated intravascular coagulation; both of these organisms were recovered on blood culture, although it seems...

Cite
Linscott AJ, Flamholtz RB, Shukla D, et al. Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis. Anaerobe. 2004;11(1):97-8doi: 10.1016/j.anaerobe.2004.10.002.
Linscott, A. J., Flamholtz, R. B., Shukla, D., Song, Y., Liu, C., & Finegold, S. M. (2005). Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis. Anaerobe, 11(1), 97-8. https://doi.org/10.1016/j.anaerobe.2004.10.002
Linscott, Andrea J, et al. "Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis." Anaerobe vol. 11,1 (2005): 97-8. doi: https://doi.org/10.1016/j.anaerobe.2004.10.002
Linscott AJ, Flamholtz RB, Shukla D, Song Y, Liu C, Finegold SM. Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis. Anaerobe. 2005 Feb-Apr;11(1):97-8. doi: 10.1016/j.anaerobe.2004.10.002. Epub 2004 Nov 30. PMID: 16701538.
Copy Download .nbib Format: NLM
Is the UK public ready for genetic medicine?.

Personalized medicine

Finegold P, Mathieson K, Holmes L, Boon M, Cottle M, Donnai D, Middleton-Price H.
PMID: 29783399
Per Med. 2008 Jan;5(1):65-76. doi: 10.2217/17410541.5.1.65.

While discussion about the potential for personalized medicine persists, in the UK embedding pharmacogenetics in mainstream clinical practice will also depend on high levels of confidence and trust of citizens in the motives of stakeholders. The role of Government,...

Cite
Finegold P, Mathieson K, Holmes L, et al. Is the UK public ready for genetic medicine?. Per Med. 2008;5(1):65-76doi: 10.2217/17410541.5.1.65.
Finegold, P., Mathieson, K., Holmes, L., Boon, M., Cottle, M., Donnai, D., & Middleton-Price, H. (2008). Is the UK public ready for genetic medicine?. Personalized medicine, 5(1), 65-76. https://doi.org/10.2217/17410541.5.1.65
Finegold, Peter, et al. "Is the UK public ready for genetic medicine?." Personalized medicine vol. 5,1 (2008): 65-76. doi: https://doi.org/10.2217/17410541.5.1.65
Finegold P, Mathieson K, Holmes L, Boon M, Cottle M, Donnai D, Middleton-Price H. Is the UK public ready for genetic medicine?. Per Med. 2008 Jan;5(1):65-76. doi: 10.2217/17410541.5.1.65. PMID: 29783399.
Copy Download .nbib Format: NLM
Nowgen, A Center for Genetics in Healthcare.

Personalized medicine

Middleton-Price H, Finegold P, Talks Z, Donnai D.
PMID: 29783442
Per Med. 2008 Sep;5(5):435-439. doi: 10.2217/17410541.5.5.435.

It is now widely agreed that genetics is set to play a major role in healthcare; 'personalized' medicine, new approaches for treating cancer, and stem cell therapies are typical of the exciting areas of development, whilst large-scale epidemiological studies...

Cite
Middleton-Price H, Finegold P, Talks Z, et al. Nowgen, A Center for Genetics in Healthcare. Per Med. 2008;5(5):435-439doi: 10.2217/17410541.5.5.435.
Middleton-Price, H., Finegold, P., Talks, Z., & Donnai, D. (2008). Nowgen, A Center for Genetics in Healthcare. Personalized medicine, 5(5), 435-439. https://doi.org/10.2217/17410541.5.5.435
Middleton-Price, Helen, et al. "Nowgen, A Center for Genetics in Healthcare." Personalized medicine vol. 5,5 (2008): 435-439. doi: https://doi.org/10.2217/17410541.5.5.435
Middleton-Price H, Finegold P, Talks Z, Donnai D. Nowgen, A Center for Genetics in Healthcare. Per Med. 2008 Sep;5(5):435-439. doi: 10.2217/17410541.5.5.435. PMID: 29783442.
Copy Download .nbib Format: NLM
Problem-solving, Adherence to Lifestyle Goals, and Weight Loss Among Individuals Participating in a Weight Loss Study.

International journal of behavioral medicine

Yu Y, Sereika SM, Finegold DN, Burke LE.
PMID: 32681361
Int J Behav Med. 2021 Jun;28(3):328-336. doi: 10.1007/s12529-020-09922-4.

BACKGROUND: The role of problem-solving is not well understood in behavioral weight loss interventions. In a 12-month behavioral weight loss study, we examined whether problem-solving changed over time and the relationships between problem-solving and changes in adherence to calorie,...

Cite
Yu Y, Sereika SM, Finegold DN, et al. Problem-solving, Adherence to Lifestyle Goals, and Weight Loss Among Individuals Participating in a Weight Loss Study. Int J Behav Med. 2021;28(3):328-336doi: 10.1007/s12529-020-09922-4.
Yu, Y., Sereika, S. M., Finegold, D. N., & Burke, L. E. (2021). Problem-solving, Adherence to Lifestyle Goals, and Weight Loss Among Individuals Participating in a Weight Loss Study. International journal of behavioral medicine, 28(3), 328-336. https://doi.org/10.1007/s12529-020-09922-4
Yu, Yang, et al. "Problem-solving, Adherence to Lifestyle Goals, and Weight Loss Among Individuals Participating in a Weight Loss Study." International journal of behavioral medicine vol. 28,3 (2021): 328-336. doi: https://doi.org/10.1007/s12529-020-09922-4
Yu Y, Sereika SM, Finegold DN, Burke LE. Problem-solving, Adherence to Lifestyle Goals, and Weight Loss Among Individuals Participating in a Weight Loss Study. Int J Behav Med. 2021 Jun;28(3):328-336. doi: 10.1007/s12529-020-09922-4. PMID: 32681361.
Copy Download .nbib Format: NLM
Intrahepatic Cholestasis, Refractory Epilepsy, Skeletal Dysplasia, Endocrine Failure, and Dysmorphic Features in a Child With a Monoallelic 2q24-32.2 Deletion Encompassing ABCB11.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Starosta RT, Granadillo JL, Patel KR, Finegold MJ, Stoll J, Kulkarni S.
PMID: 34428094
Pediatr Dev Pathol. 2021 Aug 24;10935266211036084. doi: 10.1177/10935266211036084. Epub 2021 Aug 24.

We report a newborn who presented with multiple limb and facial anomalies, endocrine disorders, and progressively worsening low-GGT cholestasis. A liver biopsy revealed hepatocellular cholestasis with giant cell transformation. Immunohistochemical staining revealed complete absence of BSEP protein compared to...

Cite
Starosta RT, Granadillo JL, Patel KR, et al. Intrahepatic Cholestasis, Refractory Epilepsy, Skeletal Dysplasia, Endocrine Failure, and Dysmorphic Features in a Child With a Monoallelic 2q24-32.2 Deletion Encompassing ABCB11. Pediatr Dev Pathol. 2021;10935266211036084doi: 10.1177/10935266211036084.
Starosta, R. T., Granadillo, J. L., Patel, K. R., Finegold, M. J., Stoll, J., & Kulkarni, S. (2021). Intrahepatic Cholestasis, Refractory Epilepsy, Skeletal Dysplasia, Endocrine Failure, and Dysmorphic Features in a Child With a Monoallelic 2q24-32.2 Deletion Encompassing ABCB11. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 10935266211036084. https://doi.org/10.1177/10935266211036084
Starosta, Rodrigo Tzovenos, et al. "Intrahepatic Cholestasis, Refractory Epilepsy, Skeletal Dysplasia, Endocrine Failure, and Dysmorphic Features in a Child With a Monoallelic 2q24-32.2 Deletion Encompassing ABCB11." Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society vol. (2021): 10935266211036084. doi: https://doi.org/10.1177/10935266211036084
Starosta RT, Granadillo JL, Patel KR, Finegold MJ, Stoll J, Kulkarni S. Intrahepatic Cholestasis, Refractory Epilepsy, Skeletal Dysplasia, Endocrine Failure, and Dysmorphic Features in a Child With a Monoallelic 2q24-32.2 Deletion Encompassing ABCB11. Pediatr Dev Pathol. 2021 Aug 24;10935266211036084. doi: 10.1177/10935266211036084. Epub 2021 Aug 24. PMID: 34428094.
Copy Download .nbib Format: NLM
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ.
PMID: 34874751
J Clin Oncol. 2021 Dec 07;JCO2100803. doi: 10.1200/JCO.21.00803. Epub 2021 Dec 07.

PURPOSE: Small cell undifferentiated (SCU) histology in hepatoblastoma (HB) tumors has historically been associated with a poor prognosis. Tumors from patients enrolled on Children's Oncology Group (COG) study AHEP0731 underwent institutional and central pathologic review for identification of SCU...

Cite
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, et al. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2021;JCO2100803doi: 10.1200/JCO.21.00803.
Trobaugh-Lotrario, A., Katzenstein, H. M., Ranganathan, S., Lopez-Terrada, D., Krailo, M. D., Piao, J., Chung, N., Randazzo, J., Malogolowkin, M. H., Furman, W. L., McCarville, E. B., Towbin, A. J., Tiao, G. M., Dunn, S. P., Langham, M. R., McGahren, E. D., Feusner, J., Rodriguez-Galindo, C., Meyers, R. L., O'Neill, A. F., & Finegold, M. J. (2021). Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2100803. https://doi.org/10.1200/JCO.21.00803
Trobaugh-Lotrario, Angela, et al. "Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2100803. doi: https://doi.org/10.1200/JCO.21.00803
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2021 Dec 07;JCO2100803. doi: 10.1200/JCO.21.00803. Epub 2021 Dec 07. PMID: 34874751.
Copy Download .nbib Format: NLM
Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to .

World journal of clinical cases

Czubkowski P, Thompson RJ, Jankowska I, Knisely AS, Finegold M, Parsons P, Cielecka-Kuszyk J, Strautnieks S, Pawłowska J, Bull LN.
PMID: 34046462
World J Clin Cases. 2021 May 26;9(15):3631-3636. doi: 10.12998/wjcc.v9.i15.3631.

BACKGROUND: Functioning farnesoid X receptor (FXR; encoded by CASE SUMMARY: A boy had severe neonatal cholestasis with moderate hypercholanemia and persistently elevated alpha-fetoprotein. Despite medical treatment, coagulopathy was uncontrollable, prompting liver transplantation at age 8 mo with incidental splenectomy....

Cite
Czubkowski P, Thompson RJ, Jankowska I, et al. Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to . World J Clin Cases. 2021;9(15):3631-3636doi: 10.12998/wjcc.v9.i15.3631.
Czubkowski, P., Thompson, R. J., Jankowska, I., Knisely, A. S., Finegold, M., Parsons, P., Cielecka-Kuszyk, J., Strautnieks, S., Pawłowska, J., & Bull, L. N. (2021). Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to . World journal of clinical cases, 9(15), 3631-3636. https://doi.org/10.12998/wjcc.v9.i15.3631
Czubkowski, Piotr, et al. "Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to ." World journal of clinical cases vol. 9,15 (2021): 3631-3636. doi: https://doi.org/10.12998/wjcc.v9.i15.3631
Czubkowski P, Thompson RJ, Jankowska I, Knisely AS, Finegold M, Parsons P, Cielecka-Kuszyk J, Strautnieks S, Pawłowska J, Bull LN. Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to . World J Clin Cases. 2021 May 26;9(15):3631-3636. doi: 10.12998/wjcc.v9.i15.3631. PMID: 34046462; PMCID: PMC8130085.
Copy Download .nbib Format: NLM
Composition and thermal properties of membrane lipids in cryptoendolithic lichen microbiota from antarctica.

Applied and environmental microbiology

Finegold L, Singer MA, Federle TW, Vestal JR.
PMID: 16348165
Appl Environ Microbiol. 1990 Apr;56(4):1191-4. doi: 10.1128/aem.56.4.1191-1194.1990.

In Antarctica there exists a cryptoendolithic microbiota which survives extremely low temperatures. Fatty acid analysis of the membrane phospholipids of this microbial community showed a predominance of polyunsaturated fatty acids. Artificial membranes made from the purified community phospholipids remained...

Cite
Finegold L, Singer MA, Federle TW, et al. Composition and thermal properties of membrane lipids in cryptoendolithic lichen microbiota from antarctica. Appl Environ Microbiol. 1990;56(4):1191-4doi: 10.1128/aem.56.4.1191-1194.1990.
Finegold, L., Singer, M. A., Federle, T. W., & Vestal, J. R. (1990). Composition and thermal properties of membrane lipids in cryptoendolithic lichen microbiota from antarctica. Applied and environmental microbiology, 56(4), 1191-4. https://doi.org/10.1128/aem.56.4.1191-1194.1990
Finegold, L, et al. "Composition and thermal properties of membrane lipids in cryptoendolithic lichen microbiota from antarctica." Applied and environmental microbiology vol. 56,4 (1990): 1191-4. doi: https://doi.org/10.1128/aem.56.4.1191-1194.1990
Finegold L, Singer MA, Federle TW, Vestal JR. Composition and thermal properties of membrane lipids in cryptoendolithic lichen microbiota from antarctica. Appl Environ Microbiol. 1990 Apr;56(4):1191-4. doi: 10.1128/aem.56.4.1191-1194.1990. PMID: 16348165; PMCID: PMC184371.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries